Clinical Trial Update: Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye [NA]

View source ↗

Summary

A completed clinical trial evaluated intravitreal triamcinolone and retrobulbar chlorpromazine as alternative approaches to managing pain in a painful blind eye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blindness
• Glaucoma

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• Thorazine (Chlorpromazine hydrochloride)

Snippet

Sponsor: Hospital Governador Celso Ramos | Conditions: Blind Painful Eye, Refractory Glaucoma | NA | Status: COMPLETED